Skip to content
Evigrade
MajorVitamin K antagonist anticoagulants×Fat-soluble vitamin E

Updated · Methodology

Mechanism

Acenocoumarol is a coumarin derivative and vitamin K antagonist: it reduces the activation of the vitamin K-dependent clotting factors II, VII, IX and X. Its effect is measured by the prothrombin time and the international normalised ratio (INR) (acenocoumarol summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The originator acenocoumarol SmPC lists vitamin E (alpha-tocopherol) among drugs that potentiate the anticoagulant effect or can impair haemostasis and increase the risk of bleeding (AEMPS). According to the vitamin E SmPC, high doses of 300 mg a day or more given with oral anticoagulants can prolong the prothrombin time. In people taking vitamin K antagonists, alpha-tocopheryl acetate has been reported to change the INR and prothrombin time, which can increase the risk of bleeding (vitamin E SmPC, AEMPS). Excess vitamin E can antagonise vitamin K and inhibit prothrombin production (AEMPS).

Symptoms

The main risk is bleeding. According to the vitamin E summary of product characteristics (SmPC), alpha-tocopheryl acetate can increase the risk of bleeding in people taking vitamin K antagonists. The adverse effects of vitamin E itself include an increased bleeding tendency with long-term doses above 800 IU a day. Gum bleeding can also occur, rarely, with long-term doses above 400–800 IU a day (vitamin E SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Acenocoumarol can cause serious bleeding, including haemorrhagic shock, and fatal bleeding. The risk is higher with an international normalised ratio (INR) above 4.0, at age 65 or older and with concomitant treatment (acenocoumarol SmPC, AEMPS). With excess acenocoumarol, the most frequent signs are bleeding into the skin and blood in the urine. Other signs include bruising, gastrointestinal, uterine, nose and gum bleeding, vomiting blood and bleeding into joints (AEMPS).

Management

The originator acenocoumarol summary of product characteristics (SmPC) lists vitamin E among drugs whose combination with acenocoumarol is generally not recommended unless strictly indicated. If the drugs are still given together, check coagulation more often (acenocoumarol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). This SmPC sets no vitamin E dose threshold. The generic acenocoumarol SmPC places vitamin E in a milder list, among drugs that can potentiate the anticoagulant and that prescribers should take into account (AEMPS). According to the vitamin E SmPC, high doses of 300 mg a day or more can prolong the prothrombin time (vitamin E SmPC, AEMPS). Use caution when combining vitamin E with vitamin K antagonists: the anticoagulant dose may need adjusting, or vitamin E treatment may need to be reconsidered. Apart from specific disorders, generally avoid vitamin E doses of 400 IU a day or more (vitamin E SmPC, AEMPS). When the two drugs are given together, the acenocoumarol SmPCs ask for close and frequent coagulation checks, for example twice a week. This applies both after vitamin E is started and after it is stopped. Adjust the acenocoumarol dose by the prothrombin time and the international normalised ratio (INR) (acenocoumarol SmPCs, AEMPS). A change in the acenocoumarol dose does not show in the prothrombin time for at least 36 hours. Base dose adjustments on the total weekly dose, spread as evenly as possible over seven days (acenocoumarol SmPC, AEMPS). With an INR of 4.5–10 and no significant bleeding, interrupt acenocoumarol. With an INR above 10, interrupt it and give 1–5 mg of vitamin K1 by mouth. In significant bleeding, interrupt acenocoumarol and give 5–10 mg of vitamin K1 intravenously very slowly, no faster than 1 mg per minute (acenocoumarol SmPC, AEMPS).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Acenocoumarol

Other interactions with Alpha-tocopherol